ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

223
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
19 Nov 2018 07:52

Takeda/Shire IV:  Making Drug Deals

Last Monday - 12 days after Takeda Pharmaceutical (4502 JP) released earnings, and less than a week after EC Anti-Trust Phase I ended and led to a...

Logo
960 Views
Share
08 Nov 2018 16:30

Japan: Relative Price Score Update - Overbought and Oversold Sectors & Peer Groups

RELATIVE PRICE SCORE - The Relative Price Score (RPS) was introduced in an earlier insight and is a measure of stock price performance relative to...

Logo
476 Views
Share
06 Nov 2018 14:00

Smartkarma’s Week that Was in JP/​​KR: Softbank Telecom IPO & Shinsegae's Pursuit of Amazon Fresh

Below is the list of the Japan/Korea related posts put on the Smartkarma platform during the week of Oct 29.

Logo
456 Views
Share
04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
376 Views
Share
02 Nov 2018 14:50

Japan: The Evolution Of (Non-Financial) Market Leadership

28 YEARS OF NON-FINANCIAL MARKET LEADERSHIP - To offer some light relief from the current market, we have compiled a graphic illustrating the...

Logo
414 Views
Share
x